Why supplements can be risky, from overdoses to medicine interactions

Supplements sit inside the wellness routine so neatly that the risks can be easy to miss. Yet the problem is not abstract: when people combine products, exceed doses, or take them alongside prescription drugs, the results can be serious. That matters because supplement use is common in the UK, and the safety gap often leaves individuals and clinicians to catch problems only after they have started.

Why the risk is hidden in plain sight

In UK law, food supplements are concentrated sources of vitamins, minerals, or other substances with a nutritional or physiological effect, sold in dose form. They are intended to supplement the normal diet, not to treat disease. That distinction sounds simple, but it is central to the public-health problem: supplements are widely used for everyday reassurance, while their risks are often treated as an afterthought.

The scale of use makes the issue a community one, not a niche concern. Food Standards Agency consumer research found that around half of UK adults regularly take food supplements, and a further third have taken them in the past. When so many people are using them, even small misunderstandings about dose, overlap, or interactions can affect large numbers of households.

When more is not better

One of the most common dangers is accidental overuse. People often buy several products aimed at different goals, such as multivitamins, vitamin D, iron, or “immune support” formulas, without checking whether the ingredients overlap. That can push total intake too high, especially when products are marketed as routine wellness add-ons rather than active substances with real physiological effects.

High-strength products can be especially risky when they are prescribed or used without careful monitoring. NHS England highlighted a case of oral vitamin D overdose in which the coroner recorded intestinal bleeding caused by high blood calcium levels linked to raised vitamin D levels. The case underlines how a supplement can move from preventive intent to dangerous toxicity when dosing is too aggressive or too frequent.

Medicine interactions are a real clinical issue

Supplements do not sit apart from medicine. NHS and specialist guidance warn that herbal and vitamin supplements can interact with medicines such as warfarin, which means a supplement that seems harmless can alter how a prescribed drug works. For people on medicines that already need close monitoring, the addition of an unreviewed supplement can create instability that is hard to spot quickly.

This is where the guidance gap becomes visible. Many people assume that because a product is sold over the counter, it is automatically safe to layer onto an existing treatment plan. But the burden often falls on patients to flag every capsule, tablet, tea, and extract they use, and on clinicians to ask the right questions before a problem appears.

Some products can be dangerous for specific groups

Risk is not evenly distributed. NHS guidance says beta-carotene supplements have been found to increase the risk of lung cancer in people who smoke or have been heavily exposed to asbestos at work. That is a reminder that supplements are not universally protective, and that a product that sounds health-promoting in one setting can be harmful in another.

This is also a social-equity issue. People with the least access to clear, continuous medical advice are often the ones most likely to rely on self-directed supplement use, pharmacy shelf labels, or advice passed through family and community networks. When warnings are subtle, or when a product is sold as routine nutrition rather than medication, the people at greatest risk may be the least likely to hear the caution in time.

Regulation is thinner than many consumers assume

Part of the danger lies in how these products enter the market. In the United States, the FDA says dietary supplements do not require premarket approval for safety and effectiveness before they are marketed. That does not mean supplements are unregulated, but it does mean the safety review process is different from the one used for prescription drugs.

For readers, that difference matters because it explains why safety problems can persist even when a product is widely available. A supplement can be common, legitimate, and still poorly suited to a particular person, dose, or drug regimen. The regulatory model leaves much of the risk management to labeling, post-market oversight, and the judgment of patients and clinicians.

How to tell when supplementation is actually necessary

The most useful starting point is a simple check on purpose. If a supplement is being used to correct a diagnosed deficiency, to support a pregnancy-related need, or to follow a clinician’s recommendation, it belongs in a careful plan with a known dose and a review of other medicines. If it is being added because it sounds beneficial, but without a clear reason, the value is far less certain.

A practical safety check should include three questions: • What am I already taking, including multivitamins and fortified products? • Could this interact with a prescription medicine, especially warfarin or another monitored drug? • Is there a specific reason I need this, or am I treating a guess like a diagnosis?

The National Diet and Nutrition Survey remains a key evidence base for understanding nutrient intake and nutritional status in the UK, and the latest official report covering 2019 to 2023 was published on 11 June 2025. That timeline is a reminder that supplement use is not fading into the background. It is a live public-health issue, and the safest path is to treat supplements as active products with real effects, not harmless extras on the shelf.